Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
24.91
-0.39 (-1.54%)
At close: Mar 28, 2025, 4:00 PM
24.43
-0.48 (-1.93%)
After-hours: Mar 28, 2025, 4:54 PM EDT
Pacira BioSciences Revenue
In the year 2024, Pacira BioSciences had annual revenue of $700.97M with 3.85% growth. Pacira BioSciences had revenue of $187.25M in the quarter ending December 31, 2024, with 3.32% growth.
Revenue (ttm)
$700.97M
Revenue Growth
+3.85%
P/S Ratio
1.64
Revenue / Employee
$887,299
Employees
790
Market Cap
1.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 700.97M | 25.99M | 3.85% |
Dec 31, 2023 | 674.98M | 8.16M | 1.22% |
Dec 31, 2022 | 666.82M | 125.29M | 23.14% |
Dec 31, 2021 | 541.53M | 111.89M | 26.04% |
Dec 31, 2020 | 429.65M | 8.62M | 2.05% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPCRX News
- 9 days ago - Pacira BioSciences, Inc. (PCRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 15 days ago - Pacira BioSciences: Back On An Uptrend After Positive Developments - Seeking Alpha
- 15 days ago - Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual - GlobeNewsWire
- 15 days ago - DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences - PRNewsWire
- 16 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - PRNewsWire
- 23 days ago - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira Lawsuit - PCRX - PRNewsWire
- 4 weeks ago - Pacira BioSciences, Inc. (PCRX) Q4 2024 Earnings Call Transcript - Seeking Alpha